IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 198 filers reported holding IMPAX LABORATORIES INC in Q4 2016. The put-call ratio across all filers is 269.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $1,265,000 | -73.3% | 100,000 | -50.0% | 0.63% | -25.9% |
| Q3 2016 | $4,740,000 | +196.1% | 200,000 | +300.0% | 0.84% | +44.0% |
| Q1 2016 | $1,601,000 | -25.1% | 50,000 | 0.0% | 0.59% | -16.5% |
| Q4 2015 | $2,138,000 | -19.0% | 50,000 | -33.3% | 0.70% | -32.3% |
| Q3 2015 | $2,641,000 | -54.0% | 75,000 | -40.0% | 1.04% | -42.6% |
| Q2 2015 | $5,740,000 | +63.3% | 125,000 | +66.7% | 1.81% | +22.4% |
| Q1 2015 | $3,515,000 | -44.5% | 75,000 | -62.5% | 1.48% | -51.7% |
| Q4 2014 | $6,336,000 | +434.2% | 200,000 | +300.0% | 3.06% | +383.0% |
| Q3 2014 | $1,186,000 | -47.3% | 50,000 | -33.3% | 0.63% | -39.6% |
| Q2 2014 | $2,249,000 | -41.3% | 75,000 | -48.3% | 1.05% | -40.8% |
| Q1 2014 | $3,831,000 | +204.8% | 145,000 | +190.0% | 1.77% | +147.3% |
| Q4 2013 | $1,257,000 | – | 50,000 | – | 0.72% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 5,415,600 | $162,414,000 | 1.91% |
| Broadfin Capital, LLC | 1,217,858 | $36,524,000 | 1.80% |
| NEW AMSTERDAM PARTNERS LLC/NY | 695,100 | $20,846,000 | 1.36% |
| Healthcare Value Capital, LLC | 50,000 | $1,500,000 | 1.26% |
| Iguana Healthcare Management, LLC | 75,000 | $2,249,000 | 1.05% |
| Matarin Capital Management, LLC | 78,292 | $2,347,977,000 | 1.04% |
| Independence Capital Asset Partners, LLC | 253,089 | $7,590,000 | 1.04% |
| Tekla Capital Management LLC | 344,683 | $10,337,000 | 0.95% |
| Penn Capital Management Company, LLC | 794,641 | $23,831,000 | 0.92% |
| Leonard Capital Management, Inc. | 87,661 | $2,629,000 | 0.89% |